Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the National Association of Securities Dealers, Inc. ("NASD") is contemplating terminating such registration or listing.
Appears in 8 contracts
Samples: Stock Purchase Agreement (Neurocrine Biosciences Inc), Stock Purchase Agreement (Axys Pharmecueticals Inc), Stock Purchase Agreement (Abgenix Inc)
Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") SEC or the National Association of Securities Dealers, Inc. ("NASD") is contemplating terminating such registration or listing.
Appears in 6 contracts
Samples: Securities Purchase Agreement (Inhibitex Inc), Stock Purchase Agreement (Parkervision Inc), Stock and Warrant Purchase Agreement (Parlex Corp)
Nasdaq Compliance. The Company's ’s Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "“Nasdaq National Market"”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") SEC or the National Association of Securities Dealers, Inc. ("“NASD"”) is contemplating terminating such registration or listing.
Appears in 5 contracts
Samples: Stock and Warrant Purchase Agreement (Inhibitex Inc), Stock Purchase Agreement (Rita Medical Systems Inc), Stock Purchase Agreement (Rita Medical Systems Inc)
Nasdaq Compliance. The Company's ’s Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "“Nasdaq National Market"”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") SEC or the National Association of Securities Dealers, Inc. ("“NASD"”) is currently contemplating terminating such registration or listing.
Appears in 5 contracts
Samples: Securities Purchase Agreement (Rita Medical Systems Inc), Stock and Warrant Purchase Agreement (Insmed Inc), Securities Purchase Agreement (Rita Medical Systems Inc)
Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq National Market of The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") SEC or the National Association of Securities Dealers, Inc. ("NASD") is contemplating terminating such registration or listing.
Appears in 2 contracts
Samples: Stock Purchase Agreement (Orphan Medical Inc), Stock Purchase Agreement (Orphan Medical Inc)
Nasdaq Compliance. The Company's ’s Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market, Inc. National Market (the "“Nasdaq National Market"”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "“SEC"”) or the National Association of Securities Dealers, Inc. ("“NASD"”) is contemplating terminating such registration or listing.
Appears in 1 contract
Nasdaq Compliance. The Company's Common Stock is registered pursuant to Section 12(g) of the Exchange Act and is listed on The Nasdaq National Market of The Nasdaq Stock Market, Inc. National Market (the "Nasdaq National Market"), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or de-listing the Common Stock from the Nasdaq National Market, nor has the Company received any notification that the Securities and Exchange Commission (the "SEC") or the National Association of Securities Dealers, Inc. ("NASD") is contemplating terminating such registration or listing.
Appears in 1 contract
Samples: Stock Purchase Agreement (Esperion Therapeutics Inc/Mi)
